Healthcare - Biotechnology - NASDAQ - US
$ 1.32
3.94 %
$ 84.9 M
Market Cap
-1.47
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
4.32%
Net Income
Estimate
29.65%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
SELLAS Life Sciences Group, Inc.
SLS has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart SLS
EBIT FORECAST
EBIT Forecast Chart SLS
NET INCOME FORECAST
Net Income Chart SLS